EUVIMEDEUVIMED entdecken
Open Access

Tryptophan and Kynurenine Pathway Metabolites and Psychoneurological Symptoms Among Breast Cancer Survivors

Hongjin Li, Mark B Lockwood, Judith M Schlaeger, Tingting Liu, Oana C Danciu, Ardith Z Doorenbos

Pain Management Nursing · 2023-02 · 24 (1) · 52-59

DOI: 10.1016/j.pmn.2022.09.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pain Management Nursing, 2023-02. Verfasst von Hongjin Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Development Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, Illinois. Electronic address: hongjin@u…. Hauptthemen laut MEDLINE: Breast Neoplasms, Cancer Survivors. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINR NIH HHS, NCCIH NIH HHS, National Institute of Nursing Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Among breast cancer survivors, pain, fatigue, depression, anxiety, and sleep disturbance are common psychoneurological symptoms that cluster together. Inflammation-induced activation of the tryptophan-kynurenine metabolomic pathway may play an important role in these symptoms. AIMS: This study investigated the relationship between the metabolites involved in the tryptophan-kynurenine pathway and psychoneurological symptoms among breast cancer survivors. DESIGN: Cross-sectional study. SETTING: Participants were recruited at the oncology clinic at the University of Illinois Hospital & Health Sciences System. PARTICIPANTS/SUBJECTS: 79 breast cancer survivors after major cancer treatment. METHODS: We assessed psychoneurological symptoms with the PROMIS-29 and collected metabolites from fasting blood among breast cancer survivors after major cancer treatment, then analyzed four major metabolites involved in the tryptophankynurenine pathway (tryptophan, kynurenine, kynurenic acid, and quinolinic acid). Latent profile analysis identified subgroups based on the five psychoneurological symptoms. Mann-Whitney U tests and multivariable logistic regression compared targeted metabolites between subgroups. RESULTS: We identified two distinct symptom subgroups (low, 81%; high, 19%). Compared with participants in the low symptom subgroup, patients in the high symptom subgroup had higher BMI (p = .024) and were currently using antidepressants (p = .008). Using multivariable analysis, lower tryptophan levels (p = .019) and higher kynurenine/tryptophan ratio (p = .028) were associated with increased risk of being in the high symptom subgroup after adjusting for BMI and antidepressant status. CONCLUSION: The tryptophan-kynurenine pathway and impaired tryptophan availability may contribute to the development of psychoneurological symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCancer SurvivorsHumansFemaleTryptophanKynurenineCross-Sectional Studies

Stichwörter der Autor:innen

Breast cancerKynurenineMetabolitesPsychoneurological symptomsTryptophan

Substanzen

TryptophanKynurenine

Autor:innen und Institutionen

  • Department of Human Development Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, Illinois. Electronic address: hongjin@uic.edu.
  • Department of Biobehavioral Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, Illinois.
  • Department of Human Development Nursing Science, College of Nursing, University of Illinois Chicago, Chicago, Illinois.
  • College of Nursing, Florida State University, Tallahassee, Florida.
  • College of Medicine, University of Illinois Chicago, Chicago, Illinois.

Förderung

  • NINR NIH HHS
  • NCCIH NIH HHS
  • National Institute of Nursing Research
  • NCCIH
  • National Institutes of Health

Zitieren

APA

Li, H., Lockwood, M. B., Schlaeger, J. M., Liu, T., Danciu, O. C., & Doorenbos, A. Z. (2023). Tryptophan and Kynurenine Pathway Metabolites and Psychoneurological Symptoms Among Breast Cancer Survivors. Pain Management Nursing, 24(1), 52-59. https://doi.org/10.1016/j.pmn.2022.09.002

Vancouver

Li H, Lockwood MB, Schlaeger JM, Liu T, Danciu OC, Doorenbos AZ. Tryptophan and Kynurenine Pathway Metabolites and Psychoneurological Symptoms Among Breast Cancer Survivors. Pain Management Nursing. 2023;24(1):52-59. doi:10.1016/j.pmn.2022.09.002

BibTeX
@article{Li2023,
  author = {Li, Hongjin and Lockwood, Mark B and Schlaeger, Judith M and Liu, Tingting and Danciu, Oana C and Doorenbos, Ardith Z},
  title = {Tryptophan and Kynurenine Pathway Metabolites and Psychoneurological Symptoms Among Breast Cancer Survivors},
  journal = {Pain Management Nursing},
  year = {2023},
  volume = {24},
  number = {1},
  pages = {52--59},
  doi = {10.1016/j.pmn.2022.09.002}
}
Kostenlos starten →